Visiopharm A/S is a Danish company headquartered in Hørsholm that develops AI-driven software for precision pathology. Its range covers image analysis for spatial biology (Phenoplex), a product that lets researchers train their own deep-learning apps for tissue research (Discovery), and IVDR-certified CE-IVD apps for biomarker assessment in breast, lung and prostate cancer. The website does not state whether the software runs in the cloud or on premises.
Visiopharm describes itself as a privately owned company and names no majority owner, so no foreign parent is named. Its privacy policy states that it is prepared to comply with the GDPR, that data processing agreements apply where it processes data on a customer's behalf, and that transfers to the United States rely on EU standard contractual clauses and a transfer impact assessment. The product pages do not state where customer data is stored. A European organisation should therefore confirm the storage location and deployment model before use.